C&R Research, Inc. is engaged in providing clinical research services. Its services include research and development of drugs and medicaments. The company was founded in 1997 and is headquartered in Seoul, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 359090 is 1,156 KRW — it has increased by 1.34% in the past 24 hours. Watch C&R RESEARCH stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange C&R RESEARCH stocks are traded under the ticker 359090.
359090 stock has risen by 14.07% compared to the previous week, the month change is a −8.17% fall, over the last year C&R RESEARCH has showed a −2.12% decrease.
359090 reached its all-time high on Sep 29, 2021 with the price of 3,200 KRW, and its all-time low was 980 KRW and was reached on Aug 5, 2024. View more price dynamics on 359090 chart. See other stocks reaching their highest and lowest prices.
359090 stock is 3.08% volatile and has beta coefficient of −0.18. Track C&R RESEARCH stock price on the chart and check out the list of the most volatile stocks — is C&R RESEARCH there?
Today C&R RESEARCH has the market capitalization of 64.38 B, it has increased by 6.87% over the last week.
Yes, you can track C&R RESEARCH financials in yearly and quarterly reports right on TradingView.
359090 net income for the last quarter is 1.98 B KRW, while the quarter before that showed 1.26 B KRW of net income which accounts for 57.37% change. Track more C&R RESEARCH financial stats to get the full picture.
No, 359090 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 25, 2024, the company has 512.00 employees. See our rating of the largest employees — is C&R RESEARCH on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. C&R RESEARCH EBITDA is 8.08 B KRW, and current EBITDA margin is 13.39%. See more stats in C&R RESEARCH financial statements.
Like other stocks, 359090 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade C&R RESEARCH stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So C&R RESEARCH technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating C&R RESEARCH stock shows the sell signal. See more of C&R RESEARCH technicals for a more comprehensive analysis. If you're still not sure, try looking for inspiration in our curated watchlists.